Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
42 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Az Sint-Lucas
Bruges, Belgium
Terminated - Uz Antwerp
Edegem, Belgium
Terminated - Az Maria Middelares
Ghent, Belgium
Terminated - Uz Gent
Ghent, Belgium
Withdrawn - Jolimont Hospital
La Louvière, Belgium
Terminated - Az Delta
Roeselare, Belgium
Terminated
- Va Loma Linda Healthcare System
Loma Linda, California, United States
Terminated - Sutter Cancer Center Sacramento
Sacramento, California, United States
Recruiting - Rocky Mountain Cancer Centers
Denver, Colorado, United States
Withdrawn - Comprehensive Cancer Care and Research Institute of Colorado, Cccric
Englewood, Colorado, United States
Withdrawn - Georgetown University
Washington D.C., District of Columbia, United States
Withdrawn - Sibley Memorial Hospital - A Member of Johns Hopkins Medicine
Washington D.C., District of Columbia, United States
Recruiting - 21st Century Oncology
Fort Myers, Florida, United States
Terminated - Miami Cancer Center
Miami, Florida, United States
Recruiting - Sarasota Memorial Health Care System
Sarasota, Florida, United States
Recruiting - Moffitt Cancer Center
Tampa, Florida, United States
Terminated - Asclepes Research Centers
Weeki Wachee, Florida, United States
Terminated - Piedmont-Columbus Regional - John B. Amos Cancer Center
Columbus, Georgia, United States
Withdrawn - University of Iowa Hospitals and Clinics - Holden Comprehensive Cancer Center
Iowa City, Iowa, United States
Recruiting - Ochsner Clinic Foundation
New Orleans, Louisiana, United States
Withdrawn - Lsu Health Shreveport
Shreveport, Louisiana, United States
Withdrawn - Medstar Franklin Square
Baltimore, Maryland, United States
Terminated - University of Nebraska Medical Center
Omaha, Nebraska, United States
Recruiting - Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States
Terminated - Md Anderson Cancer Center at Cooper Hospital
Camden, New Jersey, United States
Terminated - Atlantic Health System - Morristown Medical Center
Morristown, New Jersey, United States
Withdrawn - Albany Stratton Va Medical Center
Albany, New York, United States
Withdrawn - Feinstein Institutes for Medical Research - Northwell Health
Manhasset, New York, United States
Recruiting - Columbia University Medical Center
New York, New York, United States
Active, not recruiting - Montefiore Hospital
The Bronx, New York, United States
Terminated - Levine Cancer Institute - Atrium Health
Charlotte, North Carolina, United States
Recruiting - East Carolina University
Greenville, North Carolina, United States
Recruiting - Wake Forest Baptist Comprehensive Cancer Center
Winston-Salem, North Carolina, United States
Active, not recruiting - Oklahoma University - Stephenson Cancer Center
Oklahoma City, Oklahoma, United States
Recruiting - Oregon Health & Science University
Portland, Oregon, United States
Recruiting - University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
Recruiting - Medical University of South Carolina - Hollings Cancer Center
Charleston, South Carolina, United States
Active, not recruiting - Prisma Health (formerly Greenville Health System)
Greenville, South Carolina, United States
Recruiting - Sarah Cannon Research Institute
Nashville, Tennessee, United States
Withdrawn - University of Texas Southwestern Medical Center
Dallas, Texas, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 12 Mar 2018
- Primary completion
- 30 Jun 2026
- Completion
- 30 Sept 2026
- Last update posted
- 14 Nov 2025
- Registered enrollment
- 190
- Registry id
- NCT03257033
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.